| Financial Year |
March 31 2023 |
| Monetary Funds |
1,854,393,574.82 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
275,807,562.61 |
| Advances to Suppliers |
15,325,210.83 |
| Other Receivables |
3,977,476.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
338,529,900.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
89,982,320.39 |
| Total Current Assets |
3,022,631,384.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
219,625,070.97 |
| Investment Properties |
-- |
| Fixed Assetes |
839,153,644.10 |
| Under-construction Projects |
867,180,492.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
126,494,938.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,112,563.68 |
| Deferred Income Tax Assets |
35,763,987.15 |
| Other Non-Current Assets |
126,864,990.02 |
| Sub-Total of Non-Current Assets |
2,242,902,713.62 |
| Total Assets |
5,265,534,097.78 |
| Short-Term Loans |
4,935,784.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
558,037,605.92 |
| Accounts Payable |
243,245,536.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,049,578.17 |
| Taxes Payable |
38,978,740.74 |
| Interest Payable |
-- |
| Dividend Payable |
7,200,000.00 |
| Other payables |
21,330,447.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,213,255.18 |
| Other Current Liabilities |
830,480.71 |
| Sub-Total of Current Liabilities |
934,311,533.16 |
| Long-term Loans |
76,023,610.73 |
| Bonds Payable |
835,609,991.11 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,711,174.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
971,348,081.13 |
| Total Liabilities |
1,905,659,614.29 |
| Paid-In Capital(Or Share Stock) |
180,001,968.00 |
| Capital Surplus |
688,249,726.50 |
| Surplus Reserve |
90,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,452,544,552.21 |
| Minority Stockholder's Interest |
722,608,252.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,637,266,231.16 |
| Owner's Equity（Stockholder's Equity） |
3,359,874,483.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,265,534,097.78 |
